Jak-STAT signaling pathway inhibition is involved in anti-tumor activity in several pre-clinical studies and continued activation of STAT1 and STAT2,which are essential components of JAK/STAT pathway, are associated with suppressing tumor apoptosis [45, 46]. Here, STAT2 is linked to neoplasm.